United States. Department of Health and Human Services. Office of Inspector General. (2011). Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D. Department of Health and Human Services, Office of Inspector General.
Chicago Style (17th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. Higher Rebates for Brand-name Drugs Result in Lower Costs for Medicaid Compared to Medicare Part D. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General, 2011.
MLA (9th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. Higher Rebates for Brand-name Drugs Result in Lower Costs for Medicaid Compared to Medicare Part D. Department of Health and Human Services, Office of Inspector General, 2011.